What is West Pharmaceutical Services EV-to-EBITDA?
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, West Pharmaceutical Services's enterprise value is $27,769 Mil.
West Pharmaceutical Services's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $844 Mil. Therefore, West Pharmaceutical Services's EV-to-EBITDA for today is 32.89.
The historical rank and industry rank for West Pharmaceutical Services's EV-to-EBITDA or its related term are showing as below:
WST'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.66 Med: 23.73 Max: 48.35
Current: 32.89
During the past 13 years, the highest EV-to-EBITDA of West Pharmaceutical Services was 48.35. The lowest was 11.66. And the median was 23.73.
WST's EV-to-EBITDA is ranked worse than 81.6% of 489
companies
in the Medical Devices & Instruments industry
Industry Median: 15.23
vs WST: 32.89
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), West Pharmaceutical Services's stock price is $376.82.
West Pharmaceutical Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.880. Therefore, West Pharmaceutical Services's PE Ratio for today is 47.82.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
West Pharmaceutical Services EV-to-EBITDA Historical Data
The historical data trend for West Pharmaceutical Services's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of West Pharmaceutical Services's EV-to-EBITDA
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's EV-to-EBITDA falls into.
West Pharmaceutical Services EV-to-EBITDA Calculation
West Pharmaceutical Services's EV-to-EBITDA for today is calculated as:
West Pharmaceutical Services's current Enterprise Value is $27,769 Mil.
West Pharmaceutical Services's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $844 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
West Pharmaceutical Services (NYSE:WST) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
West Pharmaceutical Services's PE Ratio for today is calculated as:
West Pharmaceutical Services's share price for today is $376.82.
West Pharmaceutical Services's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
West Pharmaceutical Services EV-to-EBITDA Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
West Pharmaceutical Services (West Pharmaceutical Services) Business Description
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WST has been successfully added to your 